NCT03014804

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: WITHDRAWN

Phase: PHASE2

Sponsor: Jonsson Comprehensive Cancer Center

Condition: Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma, Recurrent Glioblastoma, Small Cell Glioblastoma

Signal summary

Public flags

Status signal: Registry Stop Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: rare_population_signal | strict_eligibility_signal | complex_intervention_signal

Stopped reason

Context when available

Final contract negotiations